Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor
Clinical trial NCT02601274 · TERMINATED
Trial details
- NCT number
- NCT02601274
- Sponsor
- Hutchison Medipharma Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.